Adjuvant chemoradiation in stage III-IV radically resected gastric cancer patients: a pilot study

被引：0
|
作者：
Orditura, M. [1 ]
Martinelli, E. [1 ]
De Vita, F. [1 ]
Galizia, G. [1 ]
Muto, P. [2 ]
Vitiello, F. [1 ]
Romano, A. [1 ]
Troiani, T. [1 ]
Morgillo, F. [1 ]
Ciardiello, F. [1 ]
机构：
[1] Univ Naples 2, Dipartimento Med Clin Sperimentale F Magrassi & A, Policlin 2, Naples, Italy
[2] Univ Naples 2, Div Radiotherapy, Naples, Italy
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)71272-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：376 / 376
页数：1
相关论文
共 50 条
  • [1] Adjuvant Chemoradiotherapy in Patients With Stage III or IV Radically Resected Gastric Cancer A Pilot Study
    Orditura, Michele
    De Vita, Ferdinando
    Muto, Paolo
    Vitiello, Fabiana
    Murino, Paola
    Lieto, Eva
    Vecchione, Loredana
    Romano, Anna
    Martinelli, Erika
    Renda, Andrea
    Ferraraccio, Francesca
    Del Genio, Alberto
    Ciardiello, Fortunato
    Galizia, Gennaro
    [J]. ARCHIVES OF SURGERY, 2010, 145 (03) : 233 - 238
  • [2] POST-OPERATIVE XELOX AND CHEMORADIATION IN STAGE III-IV RADICALLY RESECTED GASTRIC CANCER PATIENTS: PRELIMINARY RESULTS OF A PILOT STUDY
    Orditura, Michele
    Martinelli, Erika
    Morgillo, Floriana
    Cecere, Sabrina
    Romano, Anna
    Murino, Paola
    Ravo, Enzo
    Galizia, Gennaro
    Renda, Andrea
    Conzo, Giovanni
    De Vita, Ferdinando
    Ciardiello, Fortunato
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : v52 - v53
  • [3] ADJUVANT CHEMORADIATION WITH BIWEEKLY OXALIPLATIN PLUS INFUSIONAL 5-FLUOROURACIL AND FOLINIC ACID REGIMEN IN STAGE III-IV RADICALLY RESECTED GASTRIC CANCER PATIENTS: A PILOT STUDY
    Orditura, Michele
    De Vita, Ferdinando
    Muto, Paolo
    Vitiello, Fabiana
    Murino, Paola
    Lieto, Eva
    Vecchione, Loredana
    Romano, Anna
    Martinelli, Erika
    Renda, Andrea
    Ferraraccio, Francesca
    Del Genio, Alberto
    Galizia, Gennaro
    Ciardiello, Fortunato
    Catalano, Giuseppe
    [J]. ANNALS OF ONCOLOGY, 2009, 20
  • [4] Radical chemoradiation in stage III-IV cervix cancer: Pilot study
    Lozano, MA
    Calvo, FA
    Sanchez, E
    Davila, E
    Zomeno, M
    Herranz, R
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 966 - 966
  • [5] Neoadjvuant versus adjuvant pembrolizumab for resected stage III-IV melanoma (SWOG S1801)
    Patel, S.
    Othus, M.
    Prieto, V.
    Lowe, M.
    Buchbinder, E.
    Chen, Y.
    Hyngstrom, J.
    Lao, C. D.
    Truong, T-G.
    Chandra, S.
    Kendra, K.
    Devoe, C.
    Hedge, A.
    Mangla, A.
    Sharon, E.
    Korde, L.
    Moon, J.
    Sondak, V.
    Ribas, A.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S1408 - S1408
  • [6] Association of Smoking History with Cancer Recurrence and Survival in Stage III-IV Male Gastric Cancer Patients
    Han, Mi Ah
    Kim, Young-Woo
    Choi, Il Ju
    Oh, Myueng Guen
    Kim, Chan Gyoo
    Lee, Jong Yeul
    Cho, Soo-Jeong
    Eom, Bang Wool
    Yoon, Hong Man
    Ryu, Keun Won
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (10) : 1805 - 1812
  • [7] Postoperative adjuvant chemoradiation therapy for patients with resected gastric cancer: Intergroup 116
    Kelsen, DP
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (21) : 32S - 34S
  • [8] Postoperative adjuvant chemoradiation therapy for patients with resected gastric cancer: Intergroup 116
    Schwarz, RE
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (06) : 1879 - 1879
  • [9] The Efficacy of Adjuvant Chemotherapy in Patients With Stage II/III Resected Rectal Cancer Treated With Neoadjuvant Chemoradiation Therapy
    Ahn, Daniel H.
    Wu, Christina
    Wei, Lai
    Williams, Terence M.
    Wuthrick, Evan
    Abdel-Misih, Sherif
    Harzman, Alan
    Husain, Syed
    Schmidt, Carl
    Goldberg, Richard M.
    Bekaii-Saab, Tanios
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2017, 40 (06): : 531 - 534
  • [10] Radically resected stage III colorectal cancer: sidedness and prognosis
    Massucci, M.
    Francesca, A.
    Veronica, M.
    Palloni, A.
    Frega, G.
    Ferracin, M.
    Porcellini, E.
    Brandi, G.
    Biasco, G.
    Garajova, I.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
12345